Camberwell, 3124, VIC,
Australia
Neuren Pharmaceuticals Technographics
Neuren Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Neuren Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 30 Neuren Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Neuren Pharmaceuticals has purchased the following applications: Microsoft 365 for Collaboration in 2017, Egnyte Life Sciences for Content Management in 2023, Google Tag Manager for Tag Management in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Neuren Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Microsoft , Egnyte , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Neuren Pharmaceuticals revenues, which have grown to $132.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Neuren Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Neuren Pharmaceuticals Tech Stack and Enterprise Applications
Neuren Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
|
Neuren Pharmaceuticals Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Egnyte | Legacy | Egnyte Life Sciences | Content Management | Content Management | n/a | 2023 | 2023 |
In 2023, Neuren Pharmaceuticals implemented Egnyte Life Sciences as a validated eQMS to meet 21 CFR Part 11 and GxP requirements. The deployment used Egnyte Life Sciences within the Content Management category to provision distinct domains for test, validated GxP workflows, and non GxP collaboration, separating compliance bound content from routine team collaboration.
Neuren completed a full eQMS deployment in 12 weeks, configuring document control, validation management, and training record workflows inside the validated GxP domain. Operational scope focused on Australia where the rollout achieved nearly 100% training compliance, with quality and regulatory teams using Egnyte Life Sciences for controlled documents, audit readiness, and formal governance around document approvals and training sign off.
|
|
|
|
|
Digital Signing | Content Management |
|
2025 | 2025 |
|
Neuren Pharmaceuticals CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Legacy | Google Tag Manager | Tag Management | CRM | n/a | 2022 | 2022 |
|
Neuren Pharmaceuticals IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2025 | 2025 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2024 | 2024 |
|
|
|
|
|
Domain Name System (DNS) | IaaS |
|
2017 | 2017 |
|
|
|
|
|
Network Management and Monitoring | IaaS |
|
2023 | 2023 |
|
Neuren Pharmaceuticals CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2014 | 2014 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2016 | 2016 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2014 | 2014 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2020 | 2020 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2023 | 2023 |
|
IT Decision Makers and Key Stakeholders at Neuren Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Neuren Pharmaceuticals Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||